Actieve functies van Vikram Sudarsan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Engrail Therapeutics, Inc.
 Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Directeur/Bestuurslid | 01-07-2019 | - |
| Algemeen Directeur | 01-07-2019 | - | |
| President | 01-07-2019 | - |
Loopbaan van Vikram Sudarsan
Eerdere bekende functies van Vikram Sudarsan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Chase Pharmaceuticals Corp.
 Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Directeur/Bestuurslid | 12-05-2014 | - |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| President | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Health Technology |
Engrail Therapeutics, Inc.
Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Beurs
- Insiders
- Vikram Sudarsan
- Ervaring
